Alzheimer’S Disease Disease – Global Clinical Trials Review, H1 2020

Pages: 1130 Published: May 30, 2020 Report Code: GDHC6207CTIDB

GlobalData's clinical trial report, “Alzheimer's Disease Global Clinical Trials Review, H1, 2020" provides an overview of Alzheimer's Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Alzheimer's Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma – Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

– Assists in formulating key business strategies with regards to investment

– Helps in identifying prominent locations for conducting clinical trials which saves time and cost

– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

– Supports understanding of trials count and enrollment trends by country in global therapeutics market

– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

– Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Key Players

  • Pfizer Inc

    Johnson & Johnson

    Eisai Co Ltd

    F. Hoffmann-La Roche Ltd

    Eli Lilly and Co

    Novartis AG

    AstraZeneca Plc

    Allergan Plc

    GlaxoSmithKline Plc

    The Lundbeck Foundation

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region 8

Clinical Trials and Average Enrollment by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12

Top Five Countries Contributing to Clinical Trials in Europe 13

Top Countries Contributing to Clinical Trials in North America 14

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15

Top Five Countries Contributing to Clinical Trials in Central and South America 16

Clinical Trials by G7 Countries: Proportion of Alzheimer's Disease to Central Nervous System Clinical Trials 17

Clinical Trials by Phase in G7 Countries 18

Clinical Trials in G7 Countries by Trial Status 19

Clinical Trials by E7 Countries: Proportion of Alzheimer's Disease to Central Nervous System Clinical Trials 20

Clinical Trials by Phase in E7 Countries 21

Clinical Trials in E7 Countries by Trial Status 22

Clinical Trials by Phase 23

In Progress Trials by Phase 24

Clinical Trials by Trial Status 25

Clinical Trials by End Point Status 26

Subjects Recruited Over a Period of Time 27

Clinical Trials by Sponsor Type 28

Prominent Sponsors 29

Top Companies Participating in Alzheimer's Disease Therapeutics Clinical Trials 31

Prominent Drugs 33

Latest Clinical Trials News on Alzheimer's Disease 34

Mar 09, 2020: Study shows Nilvadipine slows early-stage Alzheimer’s disease 34

Mar 05, 2020: AC Immune to present new data on neurodegenerative program ACI-35.030 at the Upcoming Advances in Alzheimer’s and Parkinson’s Therapies Focus Meeting 34

Mar 03, 2020: Alzheimer patients at Swedish clinics to be included in Phase 3 study of drug candidate BAN2401 34

Feb 27, 2020: Inflazome’s Somalix demonstrates positive safety, tolerability and pharmacodynamic profile in its phase I study 35

Feb 26, 2020: ProMIS Neurosciences initiates natural history study of blood-based biomarkers in Alzheimer’s Disease 35

Feb 20, 2020: Annovis issued patent for method of treating Parkinson’s Disease and other lewy body diseases 36

Feb 14, 2020: Annovis Bio to continue DISCOVER Alzheimer’s trial 36

Feb 12, 2020: Oligomerix presents preclinical data at TAU2020 Global Conference for small molecule inhibitor of tau self-association 36

Feb 11, 2020: Cassava Sciences announces Phase 2a study of PTI-125 published in the Journal of Prevention of Alzheimer’s Disease (JPAD) 37

Feb 11, 2020: T3D Therapeutics begins enrollment in the PIONEER Phase 2 clinical trial of T3D-959 in patients with mild to moderate alzheimer's disease 38

Clinical Trial Profile Snapshots 39

Appendix 1180

Abbreviations 1180

Definitions 1180

Research Methodology 1181

Secondary Research 1181

About GlobalData 1182

Contact Us 1182

Source 1183

List of Tables

List of Tables

Alzheimer's Disease Therapeutics, Global, Clinical Trials by Region, 2020* 8

Alzheimer's Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020* 10

Alzheimer's Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020* 11

Alzheimer's Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020* 12

Alzheimer's Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2020* 13

Alzheimer's Disease Therapeutics Clinical Trials, North America, Top Countries, 2020* 14

Alzheimer's Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2020* 15

Alzheimer's Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2020* 16

Proportion of Alzheimer's Disease to Central Nervous System Clinical Trials, G7 Countries (%), 2020* 17

Alzheimer's Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2020* 18

Alzheimer's Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020* 19

Proportion of Alzheimer's Disease to Central Nervous System Clinical Trials, E7 Countries (%), 2020* 20

Alzheimer's Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2020* 21

Alzheimer's Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020* 22

Alzheimer's Disease Therapeutics, Global, Clinical Trials by Phase, 2020* 23

Alzheimer's Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2020* 24

Alzheimer's Disease Therapeutics, Global, Clinical Trials by Trial Status, 2020* 25

Alzheimer's Disease Therapeutics Clinical Trials, Global, by End Point Status, 2020* 26

Alzheimer's Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019 27

Alzheimer's Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020* 28

Alzheimer's Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2020* 30

Alzheimer's Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020* 32

Alzheimer's Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020* 33

List of Figures

List of Figures

Alzheimer's Disease Therapeutics, Global, Clinical Trials by Region (%), 2020* 8

Alzheimer's Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020* 9

Alzheimer's Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020* 11

Alzheimer's Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2020* 12

Alzheimer's Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020* 13

Alzheimer's Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2020* 14

Alzheimer's Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2020* 15

Alzheimer's Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2020* 16

Proportion of Alzheimer's Disease to Central Nervous System Clinical Trials, G7 Countries (%), 2020* 17

Alzheimer's Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2020* 18

Alzheimer's Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020* 19

Proportion of Alzheimer's Disease to Central Nervous System Clinical Trials, E7 Countries (%), 2020* 20

Alzheimer's Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2020* 21

Alzheimer's Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020* 22

Alzheimer's Disease Therapeutics, Global, Clinical Trials by Phase (%), 2020* 23

Alzheimer's Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2020* 24

Alzheimer's Disease Therapeutics, Global, Clinical Trials by Trial Status, 2020* 25

Alzheimer's Disease Therapeutics Clinical Trials, Global, by End Point Status, 2020* 26

Alzheimer's Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019 27

Alzheimer's Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020* 28

Alzheimer's Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2020* 29

Alzheimer's Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020* 31

Alzheimer's Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020* 33

GlobalData Methodology 1181

Frequently Asked Questions

$2500

Can be used by individual purchaser only

$7500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.